NEWS RELEASE

Natural Products Association Statement on Nomination of Robert Califf, M.D., To Lead Food and Drug Administration

WASHINGTON, DC – Natural Products Association (NPA) President and CEO Dr. Daniel Fabricant, Ph.D., released the following statement in response to the nomination of Robert Califf, M.D., to lead the Food and Drug Administration (FDA).

“NPA welcomes the return of a Senate confirmed commissioner to lead the Food and Drug Administration. If confirmed, Dr. Califf will be responsible for leading the Agency during one of the most challenging moments in history. We look forward to hearing Dr. Califf’s views on enforcing DSHEA, regulating the rapidly expanding CBD industry, and addressing the issue of adulterated ingredients through the NDI process.”

###

The Supplement Safety & Compliance Initiative (SSCI) is an industry-driven initiative led by retailers to provide a harmonized benchmark to recognize various safety standards throughout the entire dietary supplement supply chain. SSCI is a bold step forward in providing quality assurance from harvest to retailer shelf. Dietary supplements must meet or exceed the SSCI benchmark to be accepted in major retailers, all with the goal of providing quality products and increasing consumer confidence. SSCI Vision: Safe and authentic dietary supplements for consumers everywhere. Visit: http://www.ssciglobal.org/